Insmed Earnings Estimate
| INSM Stock | USD 23.78 0.16 0.67% |
Insmed |
Insmed Earnings Estimation Breakdown
The calculation of earning per share of Insmed Inc is based on the official Zacks consensus of 4 analysts regarding Insmed's future annual earnings. Given the historical accuracy of 87.16%, Insmed's future earnings per share of Insmed is estimated to be -1.14 with the lowest and highest values of -1.28 and -1.06, respectively. Please note that this consensus of annual earnings estimates for Insmed Inc is an estimate of EPS before non-recurring items and includes employee stock options expenses Current EPS
-1.28 Lowest | Expected EPS | -1.06 Highest |
Insmed Earnings Projection Consensus
Suppose the current estimates of Insmed's value are higher than the current market price of the Insmed stock. In this case, investors may conclude that Insmed is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Insmed's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Current EPS | EPS Estimate for 31st of December 2023 |
| 4 | 87.16% | -5.29 | -1.14 |
Insmed Earnings per Share Projection vs Actual
Actual Earning per Share of Insmed refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Insmed Inc predict the company's earnings will be in the future. The higher the earnings per share of Insmed, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Insmed Estimated Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Insmed, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Insmed should always be considered in relation to other companies to make a more educated investment decision.Insmed Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Insmed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-10-26 | 2023-09-30 | -1.13 | -1.11 | 0.02 | 1 | ||
2023-08-03 | 2023-06-30 | -1.13 | -1.78 | -0.65 | 57 | ||
2023-05-04 | 2023-03-31 | -1.11 | -1.17 | -0.06 | 5 | ||
2023-02-23 | 2022-12-31 | -1.04 | -1.21 | -0.17 | 16 | ||
2022-10-27 | 2022-09-30 | -0.89 | -1.09 | -0.2 | 22 | ||
2022-08-04 | 2022-06-30 | -0.89 | -0.8 | 0.09 | 10 | ||
2022-05-05 | 2022-03-31 | -0.88 | -0.8 | 0.08 | 9 | ||
2022-02-17 | 2021-12-31 | -0.9 | -0.95 | -0.05 | 5 | ||
2021-10-28 | 2021-09-30 | -0.86 | -0.89 | -0.03 | 3 | ||
2021-08-05 | 2021-06-30 | -0.85 | -0.91 | -0.06 | 7 | ||
2021-05-06 | 2021-03-31 | -0.89 | -0.89 | 0 | 0 | ||
2021-02-25 | 2020-12-31 | -0.7 | -1 | -0.3 | 42 | ||
2020-10-29 | 2020-09-30 | -0.61 | -0.63 | -0.02 | 3 | ||
2020-08-06 | 2020-06-30 | -0.63 | -0.64 | -0.01 | 1 | ||
2020-04-30 | 2020-03-31 | -0.71 | -0.74 | -0.03 | 4 | ||
2020-02-25 | 2019-12-31 | -0.58 | -0.59 | -0.01 | 1 | ||
2019-10-30 | 2019-09-30 | -0.67 | -0.68 | -0.01 | 1 | ||
2019-08-01 | 2019-06-30 | -0.86 | -0.81 | 0.05 | 5 | ||
2019-05-07 | 2019-03-31 | -0.95 | -0.96 | -0.01 | 1 | ||
2019-02-22 | 2018-12-31 | -1.05 | -1.19 | -0.14 | 13 | ||
2018-10-30 | 2018-09-30 | -1.06 | -1.14 | -0.08 | 7 | ||
2018-08-02 | 2018-06-30 | -1.08 | -1 | 0.08 | 7 | ||
2018-05-02 | 2018-03-31 | -0.98 | -0.89 | 0.09 | 9 | ||
2018-02-23 | 2017-12-31 | -0.64 | -0.85 | -0.21 | 32 | ||
2017-11-02 | 2017-09-30 | -0.69 | -0.69 | 0 | 0 | ||
2017-08-03 | 2017-06-30 | -0.63 | -0.72 | -0.09 | 14 | ||
2017-05-03 | 2017-03-31 | -0.6 | -0.6 | 0 | 0 | ||
2017-02-23 | 2016-12-31 | -0.89 | -1.1 | -0.21 | 23 | ||
2016-11-03 | 2016-09-30 | -0.59 | -0.61 | -0.02 | 3 | ||
2016-08-04 | 2016-06-30 | -0.56 | -0.59 | -0.03 | 5 | ||
2016-05-05 | 2016-03-31 | -0.56 | -0.54 | 0.02 | 3 | ||
2016-02-25 | 2015-12-31 | -0.49 | -0.51 | -0.02 | 4 | ||
2015-11-06 | 2015-09-30 | -0.47 | -0.5 | -0.03 | 6 | ||
2015-08-06 | 2015-06-30 | -0.48 | -0.47 | 0.01 | 2 | ||
2015-05-07 | 2015-03-31 | -0.5 | -0.55 | -0.05 | 10 | ||
2015-02-27 | 2014-12-31 | -0.56 | -0.36 | 0.2 | 35 | ||
2014-11-06 | 2014-09-30 | -0.46 | -0.54 | -0.08 | 17 | ||
2014-08-06 | 2014-06-30 | -0.46 | -0.59 | -0.13 | 28 | ||
2014-05-08 | 2014-03-31 | -0.41 | -0.36 | 0.05 | 12 | ||
2014-03-06 | 2013-12-31 | -0.45 | -0.41 | 0.04 | 8 | ||
2013-11-05 | 2013-09-30 | -0.41 | -0.46 | -0.05 | 12 | ||
2013-08-06 | 2013-06-30 | -0.32 | -0.28 | 0.04 | 12 | ||
2013-05-07 | 2013-03-31 | -0.46 | -0.43 | 0.03 | 6 | ||
2013-03-18 | 2012-12-31 | -0.32 | -0.49 | -0.17 | 53 | ||
2012-11-07 | 2012-09-30 | -0.42 | -0.38 | 0.04 | 9 | ||
2012-08-07 | 2012-06-30 | -0.33 | -0.39 | -0.06 | 18 | ||
2012-05-08 | 2012-03-31 | -0.38 | -0.28 | 0.1 | 26 | ||
2012-03-13 | 2011-12-31 | -0.38 | -0.3 | 0.08 | 21 | ||
2011-11-08 | 2011-09-30 | -0.28 | -0.34 | -0.06 | 21 | ||
2011-08-08 | 2011-06-30 | -0.33 | -0.4 | -0.07 | 21 | ||
2011-05-11 | 2011-03-31 | -0.32 | -0.85 | -0.53 | 165 | ||
2011-03-10 | 2010-12-31 | -0.1 | -0.42 | -0.32 | 320 | ||
2010-11-03 | 2010-09-30 | None | -0.0253 | None | 0 | ||
2010-08-04 | 2010-06-30 | None | -0.029 | None | 0 | ||
2010-05-06 | 2010-03-31 | None | 0.009 | None | 0 | ||
2010-03-15 | 2009-12-31 | None | 0.1771 | None | 0 | ||
2009-11-06 | 2009-09-30 | None | -0.0116 | None | 0 | ||
2009-08-13 | 2009-06-30 | None | -0.1269 | None | 0 | ||
2009-05-13 | 2009-03-31 | None | 9.6004 | None | 0 | ||
2009-03-11 | 2008-12-31 | None | -0.3241 | None | 0 | ||
2008-10-30 | 2008-09-30 | None | -0.1768 | None | 0 | ||
2008-08-08 | 2008-06-30 | None | -0.3826 | None | 0 | ||
2008-05-08 | 2008-03-31 | None | -0.3997 | None | 0 | ||
2008-03-04 | 2007-12-31 | -0.3 | -0.3 | 0 | 0 | ||
2007-11-08 | 2007-09-30 | -0.4 | -0.3 | 0.1 | 25 | ||
2007-08-02 | 2007-06-30 | -0.5 | -0.2 | 0.3 | 60 | ||
2007-05-10 | 2007-03-31 | -0.75 | -1 | -0.25 | 33 | ||
2007-03-15 | 2006-12-31 | -1.25 | -2.1 | -0.85 | 68 | ||
2006-11-03 | 2006-09-30 | -1.05 | -1.2 | -0.15 | 14 | ||
2006-08-08 | 2006-06-30 | -1.6 | -0.9 | 0.7 | 43 | ||
2006-05-08 | 2006-03-31 | -1.3 | -1.7 | -0.4 | 30 | ||
2006-03-02 | 2005-12-31 | -2.1 | -2.7 | -0.6 | 28 | ||
2005-11-03 | 2005-09-30 | -2.1 | -2.9 | -0.8 | 38 | ||
2005-08-08 | 2005-06-30 | -2 | -1.9 | 0.1 | 5 | ||
2005-05-10 | 2005-03-31 | -1.2 | -1.3 | -0.1 | 8 | ||
2005-03-16 | 2004-12-31 | None | -1.409 | None | 0 | ||
2004-11-08 | 2004-09-30 | -1.4 | -2 | -0.6 | 42 | ||
2004-07-28 | 2004-06-30 | -3.1 | -2.3 | 0.8 | 25 | ||
2004-05-05 | 2004-03-31 | -1 | -1.2 | -0.2 | 20 | ||
2004-02-11 | 2003-12-31 | -0.8 | -0.6 | 0.2 | 25 | ||
2003-11-05 | 2003-09-30 | None | -0.6381 | None | 0 | ||
2003-07-31 | 2003-06-30 | None | -0.977 | None | 0 | ||
2003-05-05 | 2003-03-31 | None | -0.6651 | None | 0 | ||
2003-02-04 | 2002-12-31 | None | -5.594 | None | 0 | ||
2002-10-30 | 2002-09-30 | None | -1.4201 | None | 0 | ||
2002-07-29 | 2002-06-30 | None | -2.1514 | None | 0 | ||
2002-05-03 | 2002-03-31 | None | -1.8535 | None | 0 | ||
2002-01-30 | 2001-12-31 | -3 | -3 | 0 | 0 | ||
2001-11-01 | 2001-09-30 | -2.93 | -2.5 | 0.43 | 14 | ||
2001-08-02 | 2001-06-30 | -3.25 | -2.7 | 0.55 | 16 | ||
2001-03-31 | 2001-03-31 | None | -3.0753 | None | 0 | ||
2001-02-01 | 2000-12-31 | -4.45 | -2.6 | 1.85 | 41 | ||
2000-09-30 | 2000-09-30 | None | -1.9 | None | 0 | ||
2000-06-30 | 2000-06-30 | None | -47.7376 | None | 0 |
About Insmed Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Insmed earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Insmed estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Insmed fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for 2023 | ||
| Accumulated Retained Earnings Deficit | -2.7 B | -2.8 B | |
| Earning Before Interest and Taxes EBIT | -453.7 M | -465.6 M | |
| Earnings per Basic Share | (3.91) | (4.22) | |
| Earnings per Diluted Share | (3.91) | (4.22) | |
| Price to Earnings Ratio | (5.11) | (5.52) | |
| Earnings Before Interest Taxes and Depreciation Amortization EBITDA | -431.4 M | -442.8 M | |
| Earnings before Tax | -480.2 M | -492.8 M |
Insmed Investors Sentiment
The influence of Insmed's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Insmed. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Insmed's public news can be used to forecast risks associated with an investment in Insmed. The trend in average sentiment can be used to explain how an investor holding Insmed can time the market purely based on public headlines and social activities around Insmed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Insmed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Insmed's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Insmed's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Insmed.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Insmed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Insmed's short interest history, or implied volatility extrapolated from Insmed options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Insmed Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Insmed Stock analysis
When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Focused Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| CEO Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEO Directory Screen CEOs from public companies around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.29) | Revenue Per Share 2.043 | Quarterly Revenue Growth 0.167 | Return On Assets (0.36) | Return On Equity (14.53) |
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.